机译:Glasgow预后评分在肝细胞癌患者中的预后作用是系统审查和荟萃分析
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Radiofrequency Ablat Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
Chinese Acad Med Sci Dept Abdominal Surg Oncol Beijing 100021 Peoples R China;
机译:Glasgow预后评分在肝细胞癌患者中的预后作用是系统审查和荟萃分析
机译:术前白蛋白 - 胆红素等级对手术切除后肝细胞癌患者的预后作用:系统审查和荟萃分析
机译:血小板/淋巴细胞比在不同BCLC分期的肝细胞癌中的预后作用:系统评价和荟萃分析
机译:基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物,接受放射治疗
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:改良的格拉斯哥预后评分作为肾细胞癌的预后因素:系统评价和荟萃分析
机译:肝细胞癌肝切除术患者控制营养状况(Conut)评分的预后意义:系统综述与荟萃分析